Pretreatment with antilymphocyte globulin and donor cells on graft prolongation in an experimental model and some observations on graft-versus-host reaction.
Survival of Lewis X Brown Norway F1 renal allografts was prolonged in Lewis recipients by pretreatment with small numbers of donor marrow cells and low dose antilymphocyte globulin(ALG)in combination. Either marrow cells or ALG alone were ineffective at these doses. It was also shown that pretreatment with marrow cells and antilymphocyte serum (ALS) considerably suppressed the local graft-versus-host reaction.
D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D001853:Bone Marrow / Q000276:immunology*; D001854:Bone Marrow Cells; D005260:Female; D006085:Graft Survival; D006087:Graft vs Host Reaction; D016030:Kidney Transplantation; D008297:Male; D051381:Rats; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum